Author:
Grønlund Emilie,Lund Lærke,Vilsbøll Tina,Hædersdal Sofie
Abstract
This review summarises the current and possible future insulin treatment of type 2 diabetes. The type 2 diabetes treatment guidelines prioritise a person-centred approach with various options before insulin addressing cardiorenal protection. Long-acting daily insulin injections are warranted in severe hyperglycaemia or when glycaemic targets are not met. Insulin, when possible, should be combined with other agents to lower insulin dosage, weight gain and hypoglycaemia. Once-weekly insulin offers a promising treatment, reducing injection burden, enhancing treatment satisfaction, and lowering the risk of severe hypoglycaemia, potentially improving type 2 diabetes management.
Publisher
Danish Medical Association
Reference30 articles.
1. Diabetesforeningen. Diabetes i tal, 2023
2. Davies MJ, Aroda VR, Collins BS et al. Management of hyperglycemia in type 2 diabetes, 2022. Diabetes Care. 2022;45:2753-2786. https://doi.org/10.2337/dci22-0034
3. Banting FG, Best CH, Collip JB et al. Pancreatic extracts in the treatment of diabetes mellitus: preliminary report. Can Med Assoc J. 1922;12(3):141-6
4. Hirsch IB, Juneja R, Beals JM et al. The evolution of insulin and how it informs therapy and treatment choices. Endocr Rev. 2020;41(5):733-755. https://doi.org/10.1210/endrev/bnaa015
5. Tabesh M, Magliano DJ, Koye DN, Shaw JE. The effect of nurse prescribers on glycaemic control in type 2 diabetes: a systematic review and meta-analysis. Int J Nurs Stud. 2018;78:37-43. https://doi.org/10.1016/j.ijnurstu.2017.08.018